의료기기 이야기

(출처: 한국의료기기산업협회) 식품의약품안전평가원 (체외진단기기과)에서 2024년 제6회 체외진단의료기기 허가심사 민원설명회가 개최됨을 안내하였다. ▶ 일시: 2024년 06월 28일(금) 13:30~14:30▶ 장소: 온라인 (webex 화상회의)▶ 주요내용: 최신심사요건 등 규제 업데이트  :: KOREA MEDICAL DEVICES INDUSTRY ASSOCIATION :: (kmdia.or.kr) :: KOREA MEDICAL DEVICES INDUSTRY ASSOCIATION :: www.kmdia.or.kr

식품의약품안전처에서는 '체외진단의료기기 소프트웨어 변경허가 사항'에 대하여 아래와 같이 유권해석하오니 관련 업무에 참고하여 주시기 바랍니다 (출처: 한국의료기기협동조합)  [식품의약품안전처] 체외진단의료기기 소프트웨어 변경허가 관련 유권해석 알림 – 한국의료기기협동조합 (medinet.or.kr) [식품의약품안전처] 체외진단의료기기 소프트웨어 변경허가 관련 유권해석 알림식품의약품안전처에서는 '체외진단의료기기 소프트웨어 변경허가 사항'에 대하여 다음과 같이 유권해석하오니 관련 업무에 참고하여 주시기 바랍니다.medinet.or.kr

This week the UK medical device regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) announced the launch of a four-week public consultation seeking the views of various stakeholders to improve safety measures for high-risk IVDs by including Common Specification (CS) requirements in the UK legislation (Medical Devices Regulations 2002 (MDR 2002)). In addition, they also seek..

Emergo에서 아래와 같이 웨비나를 개최한다.​▶ 주제: Revised IVD Regulation RDC 830/2023▶ 일시: 2024년 04월 30일 CST 9시 (한국시간: 04월 30일 23시)  The ANVISA – Agência Nacional de Vigilância Sanitária  issued Resolution RDC No. 830/2023, on Dec. 11, 2023. The resolution is intended to help IVD medical device manufacturers determine what information is required in a registration submission. The Resolution outlines a new ..

This is the first in a series of regulatory updates on the labeling standard in Mexico.What is a medical device NOM in Mexico?In simple terms, a Norma Oficial Mexicana is a Mexican regulatory standard that manufacturers meet to protect the safety of medical device, IVD and pharmaceutical users.The Mexican Secretariat of Health is the agency in charge of enforcing the national health policy an..

식품의약품안전처 체외진단의료기기과에서는 '2024년 제4차 체외진단의료기기 허가심사 온라인 민원설명회'를 개최하였다.  민원인 안내서 > 민원설명회 자료 > 2024년 제4차 체외진단의료기기 허가심사 온라인 민원설명회 | 식품의약품안전평가원 (nifds.go.kr) 민원설명회 자료 > 2024년 제4차 체외진단의료기기 허가심사 온라인 민원설명회 |" data-og-description="2024년 제4차 체외진단의료기기 허가심사 온라인 민원설명회 발표자료를 첨부합니다. 업무에 참고하시기 바랍니다." data-og-host="www.nifds.go.kr" data-og-source-url="https://www.nifds.go.kr/brd/m_16/view.do?seq=7166&srchFr=&srchTo=..

Safety reporting in performance studies of in vitro diagnostic medical devices (IVDs) shall be performed in line with the requirements of Article 76(2) of Regulation (EU) 2017/746 – In Vitro Diagnostic Medical Device Regulation (IVDR): The sponsor shall report without delay to all Member States in which a performance study is being conducted all of the following by means of the electronic system..

As previously reported by Emergo by UL, Brazilian medical device and IVD market regulator ANVISA has released three guidance documents to further clarify Resolution RDC 830/2023. Of interest to this post is the document regarding IVDs with a changed risk classification. The IVDs are presented in five tables: Class III to Class II, Class II to Class III, Class IV to III, Class II to IV, and Class..

March in Europe The European Commission (EC) updated several medical device safety regulation documents in March 2024. This includes additional standards harmonized with the Medical Devices Regulation (2017/745, MDR) and In Vitro Diagnostics Devices Regulation (2017/746, IVDR) and published in the Official Journal of European Union (OJEU). It also includes an updated study on Notified Body appli..

Background - EURL designation 2023 In July 2022, the European Commission launched a call for the designation of EU reference laboratories in 8 categories of class D devices. Applicant laboratories had six months to prepare and submit applications to their Member State. The Commission reviewed the applications based on the following elements specified in the call: the applicant laboratories must ..